AstraZeneca is under pressure to supply the Covid-19 vaccine to Britain. The EU's health commissioner has insisted Britain should not be given priority, despite orders placed a few months ago. Stella Kyriakides says, rejecting the argument based on the first get first. It can work in any butcher shop, but not on contract.
Brussels is trying to collect millions of coronavirus vaccine doses produced for Britain by AstraZeneca. Angela Merkel Peter Lees, who is in the CDU party, had earlier said that Brussels could block the shipment of Pfizer / Bioentech made in Belgium. Meanwhile, insiders in the industry fear that Brussels could try to use Britain's vaccine as a "political statement".
If that happens, it will become a 'human rights problem for millions of people'. However, AstraZeneca officials have indicated that they will not back down from the EU's demands.
The Prime Minister of the United Kingdom Boris Johnson has said that Britain's efforts to prevent the spread of the 75 million covid vaccine are unacceptable.
Pharma giant AstraZeneca will supply about half of the vaccine to the European Union in the first half of this year.
After such news, politics has started with vaccine. By the end of March, 70 million doses of the vaccine are expected to be delivered to the region from 28 countries. However, the block will now get 31 million doses of vaccine due to production deficit.
EU Commissioner Stella Kiriakides said on Twitter that the EU and member states were "deeply disappointed" by the drop in vaccine doses. The European Commission says AstraZeneca is obliged to defend its agreement to supply the vaccine to the EU. Italy has warned that it will take action against Pfizer and AstraZeneca if the terms of the Covid-19 vaccine are violated.
"Once approved in Europe, we will not delay the delivery of the vaccine," AstraZeneca said in a statement. However, the amount of vaccine will be less than initially estimated for production complexity in the European supply chain. It added that tens of millions of doses would be delivered to the European Union in February and March. Because we are increasing the amount of production.
The EU has not yet approved the use of the Oxford vaccine. The approval is expected on January 29. Earlier, US company Pfizer also announced a reduction in vaccine supplies to the European Union. However, no reason was given by the company.
The European Commission said the Anglo-Swedish company was obliged to comply with contractual regulations despite problems with production at the Belgian site.
AstraZeneca CEO Pascal Soriot was pleased to attend a meeting with the EU Vaccine Steering Board last evening. “We had constructive and open conversations about the complexities of increasing our vaccine production and the challenges we face,” he said.
"As we continue our efforts to bring the vaccine to millions of Europeans without achieving any goals during the epidemic, we are more committed to jointly charting a goal to deliver the vaccine in the coming months," he said.
0 Comments